Application of Megavoltage Imaging to Reduce Artifact After Seed Implants

Completed

Conditions studied: Prostate Cancer

In brief

This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure in patients treated with interstitial permanent seed implants for low and intermediate risk prostate cancer. All patients will received the same standard of care treatment but will receive an additinoal CT image of the prostate.

Key facts

Study ID

NCT01810627

Run by

William St Clair

People needed

10

Starts

2013-09-01

Expected to finish

2016-04-01

Last updated by the study team

2017-09-26

Who can join

Age: 50 and older, up to 80. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Male 50-80 years of age Eligible for interstitial brachytherapy implants

Where it is running

• Markey Cancer Center — Lexington, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.